Dynamic Technology Lab Private LTD Blueprint Medicines Corp Transaction History

Dynamic Technology Lab Private LTD

  • $914 Million
  • Q3 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023
BUY
$41.06 - $66.48 $224,598 - $363,645
5,470 Added 163.28%
8,820 $386,000
Q3 2022

Nov 14, 2022
SELL
$49.93 - $77.7 $164,769 - $256,410
-3,300 Reduced 49.62%
3,350 $221,000
Q3 2022

Nov 14, 2022
SELL
$49.93 - $77.7 $164,769 - $256,410
-3,300 Reduced 49.62%
3,350 $221,000
Q2 2022

Aug 12, 2022
BUY
$45.23 - $70.15 $300,779 - $466,497
6,650 New
6,650 $336,000
Q1 2021

May 14, 2021
SELL
$90.71 - $108.28 $382,614 - $456,725
-4,218 Closed
0 $0
Q4 2020

Feb 11, 2021
BUY
$92.08 - $124.48 $388,393 - $525,056
4,218 New
4,218 $473,000

Others Institutions Holding BPMC

# of Institutions
351
Shares Held
60.3M
Call Options Held
2.25M
Put Options Held
1.18M
View Full List

About Blueprint Medicines Corp

BPMC Quotes by TradingView
  • Ticker BPMC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,719,600
  • Market Cap $5.47B
  • Description
  • Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...
More about BPMC
Track This Portfolio

Track Dynamic Technology Lab Private LTD Portfolio

Follow Dynamic Technology Lab Private LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

News

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email